Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis

British Journal of Rheumatology

Volumn 37, Issue 12, 1998, Pages 1330-1333

  Ahmadi, K ^b   Wilson, C ^a   Tiwana, H ^a   Binder, A ^c   Ebringer, A ^a,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c LISTER HOSPITAL   (United Kingdom)

^d MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Ankylosing spondylitis; Klebsiella pneumoniae; Lipopolysaccharide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM;

ADULT; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; SPONDYLITIS, ANKYLOSING;

EID: 0032413086     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Brewerton DA, Caffrey M, Hart FD, James DCO, Nicholls A, Sturrock RD. Ankylosing spondylitis and HLA.27. Lancet 1973;I:904-7.
2. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of HLA antigen W27 with ankylosing spondylitis. N Engl J Med 1973;238:704-6.
3. Trull A, Ebringer A, Panayi G, Ebringer R, James DCO. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol 1984;55:74-80.
4. Mäki-Ikola O, Lehtinen K, Granfors K, Vainionpaa R, Towanen P. Bacterial antibodies in ankylosing spondylitis. Clin Exp Immunol 1991;84:472-5.
5. Welsh J, Avakian H, Cowling P et al. Ankylosing spondylitis, HLA-B27 and Klebsiella I. Cross-reactivity studies with rabbit antisera. Br J Exp Pathol 1980;61:85-91.
6. Baines M, Ebringer A, Avakian H, Samuel D, James DCO. The use of enzyme immunoassay and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and B27 in ankylosing spondylitis patients and healthy controls. Scand J Rheumatol 1990;19:341-9.
7. Robbins JB, McCracken GH, Gotschild EC, Orskov F, Orskov L, Hanson LA. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med 1974;290:1216-20.
8. Wagener P, Bush J, Hammer M et al. Endotoxin in the plasma of patients with inflammatory rheumatic diseases. Scand J Rheumatol 1988;17:301.
9. Granfors K, Ogasawara M, Hill JL, Lahesmaa-Rantala R, Toivanen A, Yu DTY. Analysis of IgA antibodies to lipopolysaccharide in Yersinia triggered reactive arthritis. J Infect Dis 1989;159:1142-7.
10. Mäki-Ikola O, Leirisalo-Repo M, Kantele A, Toivanen P, Granfors K. Salmonella specific antibodies in reactive arthritis. J Infect Dis 1991;164:1141-8.
11. Mancini G, Carbonara HO, Heremans JF. Immuno-chemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:361-8.
12. Ebringer A. Ankylosing spondylitis is caused by Klebsiella. Rheum Dis Clin North Am 1992;18:105-21.
13. Mäki-Ikola O, Lehtinen K, Nissila M, Granfors K. IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides in patients with ankylosing spondylitis. Br J Rheumatol 1994;33:1025-9.
14. Tani Y, Sato H, Tanaka N, Hukuda S. Antibodies against bacterial lipopolysaccharides in Japanese patients with ankylosing spondylitis. Br J Rheumatol 1997; 36:491-3.
15. Mäki-Ikola O, Granfors K. Salmonella triggered reactive arthritis. Lancet 1992;339:1096-8.
16. Granfors K, Jalkanen S, Von Essen R et al. Yersinia antigens in synovial cells from patients with reactive arthritis. N Engl J Med 1989;320:216-21.
17. Granfors K, Jalkanen S, Lindberg AA et al. Salmonella lipopolysaccharide in synovial fluid cells from patients with reactive arthritis. Lancet 1990;335:685-8.
18. Taylor PW. Genetical studies of serum resistance in Escherichia coli. J Gen Microbiol 1975;89:57-66.
19. Joiner KA, Hammer CH, Brown EJ, Cole RJ, Frank MM. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal components of complement are deposited and released from Salmonella minnesota S218 without causing bacterial death. J Exp Med 1982;155:797-808.
20. Glynn AA, Howard CJ. The sensitivity to complement of strains of Escherichia coli related to their K antigens. Immunology 1970;18:331-46.
21. McCabe WR, Kaijser B, Olling S, Uwaydah M, Hanson LA. E. coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis 1978;138:33-41.
22. Ciurana B, Tomas JM. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Infect Immun 1987;55:2741-6.
23. Morrison DC, Kline LF. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides. J Immunol 1977;118:362-8.
24. Schwimmbeck P, Yu D, Oldstone M. Autoantibodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiters syndrome: Molecular mimicry with Klebsiella pneumoniae as a potential mechanism for autoimmune disease. J Exp Med 1987;166:173-81.
25. Fielder M, Pirt SJ, Tarpey I et al. Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS Lett 1995;369:243-8.
26. D'Enfert C, Reyss I, Wandersman C, Pugsley AP. Protein secretion by Gram negative bacteria. Characterisation of two membrane proteins required for pullulanase secretion by Escherichia coli K-12. J Biol Chem 1989; 264:17462-8.